C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 4 740 JPY 0.42% Market Closed
Market Cap: 38.1B JPY
Have any thoughts about
Cuorips Inc?
Write Note

Cuorips Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuorips Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuorips Inc
TSE:4894
Income from Continuing Operations
-ÂĄ632.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Income from Continuing Operations
ÂĄ5.3B
CAGR 3-Years
58%
CAGR 5-Years
49%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Income from Continuing Operations
ÂĄ17.1B
CAGR 3-Years
40%
CAGR 5-Years
46%
CAGR 10-Years
64%
Takara Bio Inc
TSE:4974
Income from Continuing Operations
ÂĄ942m
CAGR 3-Years
-62%
CAGR 5-Years
-25%
CAGR 10-Years
-5%
Pharma Foods International Co Ltd
TSE:2929
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
-20%
CAGR 5-Years
100%
CAGR 10-Years
N/A
S
StemRIM Inc
TSE:4599
Income from Continuing Operations
-ÂĄ2B
CAGR 3-Years
-51%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Cuorips Inc
Glance View

Market Cap
38B JPY
Industry
Biotechnology

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Intrinsic Value
234.89 JPY
Overvaluation 95%
Intrinsic Value
Price
C

See Also

What is Cuorips Inc's Income from Continuing Operations?
Income from Continuing Operations
-632.2m JPY

Based on the financial report for Mar 31, 2024, Cuorips Inc's Income from Continuing Operations amounts to -632.2m JPY.

What is Cuorips Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-40%

Over the last year, the Income from Continuing Operations growth was -40%.

Back to Top